AstraZeneca and Daiichi Sankyo win FDA approval for Datroway in breast cancer, edging ahead of Gilead
Antibody-drug conjugate becomes first in class to demonstrate survival benefit in front-line treatment setting
Antibody-drug conjugate becomes first in class to demonstrate survival benefit in front-line treatment setting
AstraZeneca received U.S. approval for hypertension treatment Baxfendy, giving the drugmaker a new entrant into the large and highly competitive cardiovascular market.
Marty Makary has resigned as commissioner of the US Food and Drug Administration after months of internal turmoil, with White House staff having signed off on a plan to replace him last week.
Drugmaker seeks clarity on rules as regulator suggests awareness drive could indirectly promote Mounjaro
The U.S. Food and Drug Administration (FDA) is increasing enforcement against pharmaceutical advertising, with a growing number of cease-and-desist and warning letters targeting what it sees as misleading promotional claims.
Shares in Arrowhead Pharmaceuticals rose 6.8 per cent on Wednesday after Australia's medicines regulator approved the US biotech's plozasiran therapy for an ultra-rare genetic disorder, expanding the geographic footprint of one of the most…
An April 2026 executive order from Donald Trump introduces major changes to how psychedelic drugs could be reviewed and accessed in the U.S. The policy creates two new pathways: a faster U.S. Food and Drug Administration review process…
Jazz Pharmaceuticals has secured priority review from US regulators for an expanded use of its targeted cancer therapy Ziihera, advancing the Dublin-headquartered group's bid to establish the drug as a frontline standard of care in…
Novartis has secured European Commission approval for Rhapsido, its oral chronic skin disease drug, broadening the geographic reach of one of the Swiss group's most strategically significant immunology launches and opening a new front in…
Adial Pharmaceuticals, the US clinical-stage biotech developing therapies for addiction disorders, has completed a demonstration manufacturing batch for its lead drug candidate AD04, clearing a technical prerequisite for the production of…
Agency moves to review ban on compounding pharmacies producing popular supplements amid political pressure and growing public demand
The US Food and Drug Administration has criticised Pfizer over Facebook advertisements for its cancer therapy Adcetris, saying the campaign failed to adequately communicate the drug’s approved use and safety risks.